Results

Total Results: 1,004 records

Showing results for "financial".

461. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
     February 01, 2009 - None of the authors has a financial interest in any of the products discussed in this report. … These generous benefits and requirements for financial need result in essentially no out-of-pocket (

462. Public-Reporting-Cost-Measures Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_technical-brief.pdf
     March 01, 2015 - None of the investigators have any affiliation or financial involvement that conflicts with the material … Key Informants must disclose any financial conflicts of interest greater than $10,000 and any other … Peer Reviewers must disclose any financial conflicts of interest greater than $10,000 and any other … Cost measure: A financial measure of cost, charge, reimbursement, payment, or out-of-pocket expenses … During this initial review, we prioritized financial measures of costs (i.e., measures involving dollar

463. CARDIOVASCULAR (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … ES-6 The manufacturer offers a support program to help patients who require financial support. … Aegerion Pharmaceuticals announces third- quarter 2014 financial results. [internet]. … Aegerion Pharmaceuticals announces first-quarter 2014 financial results. [internet].

464. Prioritization Criteria Methodology for Future Research Needs Proposals Within the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/future-research-prioritization-methods_research.pdf
     January 01, 2013 - None of the investigators have any affiliations or financial involvement that conflicts with the material … In recognition of the resource, human, and financial costs of conducting research, the changing determinants

465. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts

466. Menopause-Protocol-130612 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
     June 12, 2013 - Key Informants must disclose any financial conflicts of interest greater than $10,000 and any other … Technical Experts must disclose any financial conflicts of interest greater than $10,000 and any other … Potential Reviewers must disclose any financial conflicts of interest greater than $10,000 and any other … Invited Peer Reviewers may not have any financial conflict of interest greater than $10,000.

467. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
     January 01, 2012 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … One expert representing a health systems perspective stated that joint replacement is a financial mainstay

468. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … experts stated that patients will pay for this treatment out of pocket, which would increase their financial

469. Medical-Evidence-Communication Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
     July 31, 2012 - Key Informants must disclose any financial conflicts of interest greater than $10,000 and any other … Technical experts must disclose any financial conflicts of interest greater than $10,000 and any other … Potential reviewers must disclose any financial conflicts of interest greater than $10,000 and any other … Invited Peer Reviewers may not have any financial conflict of interest greater than $10,000.

470. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … annually to manage their symptoms; thus, a treatment that restores cartilage could have a significant financial

471. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - Key Informants must disclose any financial conflicts of interest greater than $10,000 and any other … Technical Experts must disclose any financial conflicts of interest greater than $10,000 and any other … Potential Reviewers must disclose any financial conflicts of interest greater than $10,000 and any other … Invited Peer Reviewers may not have any financial conflict of interest greater than $10,000.

472. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … The financial strain on the system could require payers to implement controversial coverage policies … AbbVie reports first-quarter 2015 financial results. [internet].

473. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
     December 22, 2014 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … The financial strain on the system could require payers to implement controversial coverage policies … Gilead Sciences announces third quarter 2014 financial results.

474. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts

475. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts

476. Registry of Patient Registries (RoPR): Project Overview (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-3_0.pdf
     January 01, 2012 - None of the investigators has any affiliations or financial involvement that conflicts with the materials

477. DARTNet Summary Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
     July 01, 2009 - None of the authors has a financial interest in any of the products discussed in this report. … We believe AHRQ’s renewed financial investment in the network for a second phase of work will go a … The financial model of DARTNet recognizes three distinct phases of development. … The third phase of the DARTNet Effective Health Care Research Report Number 14 33 financial … AHRQ has provided DARTNet with further financial support to move forward with its development and expansion

478. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … Early reports from financial analysts indicated that belimumab had not diffused as rapidly as expected … One expert representing a health systems perspective stated that joint replacement is a financial mainstay

479. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … Since the FDA approval in August 2012 of ranibizumab injection for DME treatment, financial analysts … Alimera Sciences reports third quarter 2012 financial results. [internet].

480. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Financial Disclosure Statement None of the individuals compiling this information has any affiliations … or financial involvement that conflicts with the material presented in this report. … Each expert uses the structured form to also disclose any potential intellectual or financial conflicts … inexpensive generic form could help to minimize health disparities; however, patients’ time and financial … available online, if fully commercialized, this intervention may not be affordable to patients of lower financial